{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:32:35Z","timestamp":1789011155936,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["2017-4389"],"award-info":[{"award-number":["2017-4389"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.leukres.2021.106753","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T12:05:03Z","timestamp":1637669103000},"page":"106753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Chronic eosinophilic leukemia with recurrent STAT5B N642H mutation\u2014An entity with features of myelodysplastic syndrome\/ myeloproliferative neoplasm overlap"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2626-4154","authenticated-orcid":false,"given":"Sreejesh","family":"Sreedharanunni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Jamwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun Vijayalakshmi","family":"Aravindan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sweta","family":"Rajpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka Rani","family":"Khadwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0949-3476","authenticated-orcid":false,"given":"Jasmina","family":"Ahluwalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2021.106753_bib0005","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.1111\/ijlh.13322","article-title":"The utility of fluorescence in situ hybridization testing in patients clinically suspected of myelodysplastic syndrome or myelodysplastic syndrome\/myeloproliferative neoplasm overlap is limited in the absence of significant morphological dysplasia","volume":"42","author":"Virk","year":"2020","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.leukres.2021.106753_bib0010","unstructured":"NGSHM - Clinical: OncoHeme Next-Generation Sequencing for Myeloid Neoplasms, Varies [Internet]. [cited 2021 Jul 28]. Available from: https:\/\/www.mayocliniclabs.com\/test-catalog\/Clinical+and+Interpretive\/63367."},{"key":"10.1016\/j.leukres.2021.106753_bib0015","doi-asserted-by":"crossref","first-page":"13210","DOI":"10.1038\/s41598-020-70093-z","article-title":"A FACS-based approach to obtain viable eosinophils from human adipose tissue","volume":"10","author":"Hernandez","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.leukres.2021.106753_bib0020","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.3324\/haematol.2014.104992","article-title":"The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse","volume":"99","author":"Bandapalli","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2021.106753_bib0025","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1172\/JCI94509","article-title":"STAT5BN642H is a driver mutation for T cell neoplasia","volume":"128","author":"Pham","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.leukres.2021.106753_bib0030","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41375-018-0342-3","article-title":"Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia","volume":"33","author":"Cross","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2021.106753_bib0035","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fimmu.2012.00234","article-title":"The STAT5b pathway defect and autoimmunity","volume":"3","author":"Kanai","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.leukres.2021.106753_bib0040","doi-asserted-by":"crossref","first-page":"E172","DOI":"10.1002\/ajh.25811","article-title":"WHO defined chronic eosinophilic leukemia, not otherwise specified (CEL, NOS): a contemporary series from the Mayo Clinic","volume":"95","author":"Morsia","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2021.106753_bib0045","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1182\/blood-2016-10-695973","article-title":"Myeloid neoplasms with eosinophilia","volume":"129","author":"Reiter","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2021.106753_bib0050","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s12288-019-01236-0","article-title":"Paratrabecular myelofibrosis and occult mastocytosis are strong morphological clues to suspect FIP1L1-PDGFRA translocation in hypereosinophilia","volume":"36","author":"Sreedharanunni","year":"2020","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"10.1016\/j.leukres.2021.106753_bib0055","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s12288-020-01343-3","article-title":"Myeloid neoplasm with t(8;22)(p11;q11): a mimicker of chronic myeloid leukaemia in blast crisis","volume":"37","author":"Kapatia","year":"2021","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"10.1016\/j.leukres.2021.106753_bib0060","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2018.052","article-title":"The Spectrum of Hypereosinophilia and associated clonal disorders - a real-world data based on combined retrospective and prospective analysis from a tropical setting","volume":"10","author":"Sreedharanunni","year":"2018","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"10.1016\/j.leukres.2021.106753_bib0065","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3389\/fimmu.2020.01765","article-title":"Eosinophilia associated with CD3\u2212CD4+ T cells: characterization and outcome of a single-center cohort of 26 patients","volume":"11","author":"Carpentier","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.leukres.2021.106753_bib0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.gendis.2019.09.007","article-title":"An updated review on phenocopies of primary immunodeficiency diseases","volume":"7","author":"Singh","year":"2020","journal-title":"Genes Dis."},{"key":"10.1016\/j.leukres.2021.106753_bib0075","series-title":"Cellular Primary Immunodeficiencies","year":"2021"},{"key":"10.1016\/j.leukres.2021.106753_bib0080","doi-asserted-by":"crossref","DOI":"10.1093\/omcr\/omaa129","article-title":"A case of hypereosinophilic syndrome with STAT5b N642H mutation","volume":"2021","author":"Ding","year":"2021","journal-title":"Oxf. Med. Case Rep."},{"key":"10.1016\/j.leukres.2021.106753_bib0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ajcp\/aqaa244","article-title":"Eosinophilia\/hypereosinophilia in the setting of reactive and idiopathic causes, well-defined myeloid or lymphoid leukemias, or germline disorders","volume":"155","author":"Kelemen","year":"2021","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.leukres.2021.106753_bib0090","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1182\/blood-2016-09-737817","article-title":"Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea","volume":"129","author":"Ma","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2021.106753_bib0095","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jaip.2020.11.050","article-title":"JAK inhibition in early-onset somatic, nonclonal STAT5B gain-of-function disease","volume":"9","author":"Eisenberg","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.leukres.2021.106753_bib0100","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3324\/haematol.2008.005447","article-title":"T-cell abnormalities are present at high frequencies in patients with hypereosinophilic syndrome","volume":"94","author":"Helbig","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2021.106753_bib0105","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/j.ejim.2016.05.024","article-title":"Frequency of abnormal T-cells in hypereosinophilic syndrome and hypereosinophilia of undetermined significance- extended follow-up","volume":"35","author":"Helbig","year":"2016","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.leukres.2021.106753_bib0110","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/sj.leu.2404670","article-title":"WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia","volume":"21","author":"Cilloni","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2021.106753_bib0115","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1038\/s41467-019-10422-7","article-title":"Structural and functional consequences of the STAT5B N642H driver mutation","volume":"10","author":"de Araujo","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621017549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621017549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:02:05Z","timestamp":1758934925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212621017549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":23,"alternative-id":["S0145212621017549"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106753","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic eosinophilic leukemia with recurrent STAT5B N642H mutation\u2014An entity with features of myelodysplastic syndrome\/ myeloproliferative neoplasm overlap","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106753"}}